<?xml version="1.0" encoding="UTF-8"?>
<p id="para180">Criteria for withdrawing a patient from study treatment were interruption of study treatment for more than 3 weeks for reasons of toxicity (or for &gt;4 weeks for reasons other than toxicity), disease progression, withdrawal of consent, unacceptable treatment-related toxicity, pregnancy, patient non-compliance, or other events precluding further administration of study drugs as judged by the study chief investigator (DC).</p>
